Purification and immunohistochemical tissue localization of human xanthine oxidase

doi:10.1016/0167-4838(93)90266-T

Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology

Volume 1164, Issue 3, 7 August 1993, Pages 327-330

Biochimica et Biophy...

https://doi.org/10.1016/0167-4838(93)90266-T Get rights and content

Abstract

Xanthine oxidase was purified 1600-fold from human liver cytosol. The purified enzyme was shown as a single band of 300 kDa on polyacrylamide gel electrophoresis and 150 kDa on SDS-PAGE. Using this purified enzyme, polyclonal antibody against xanthine oxidase was raised in a rabbit. On Ouchterlony's double immunodiffusion method, the raised antibody and the human liver cytosol made a precipitation line stained by activity stain and protein stain, respectively. With the raised anti-xanthine oxidase sera, the immunohistochemical localization of xanthine oxidase in human tissues was examined. Immunostaining of frozen hepatic tissue section showed that the cytoplasm of hepatocytes and endothelial lining cells were stained. In a number of other tissues, the xanthine oxidase antigen was detected only in the endothelial lining cells from heart, kidney, brain, aorta, lung and mesentery, except for the duodenal mucosa cells. A possible role for xanthine oxidase in the endothelial cells from various human tissues in the pathogenesis of reperfusion injury was suggested.

References (18)

M.M. Bradford
Anal. Biochem.
(1976)
D.E. Chambers et al.
J. Mol. Cell. Cardiol.
(1985)
E.D. Jarasch et al.
Cell
(1981)
T.A. Krenitsky et al.
Comp. Biochem. Physiol.
(1974)
T.A. Krenitsky et al.
Arch. Biochem. Biophys.
(1986)
O.H. Lowry et al.
J. Biol. Chem.
(1951)
T. Nishino et al.
FEBS Lett.
(1981)
W.R. Waud et al.
Arch. Biochem. Biophys.
(1976)
T. Yamamoto et al.
Biochim. Biophys. Acta
(1990)

There are more references available in the full text version of this article.

Cited by (73)

Preparation of the peroxisome proliferator-activated receptor α polyclonal antibody: Its application in fatty liver hemorrhagic syndrome
2021, International Journal of Biological Macromolecules
Citation Excerpt :
At present, the structure and function of PPARα are relatively clear, but the preparation of anti-PPARα antibody has not been reported yet in Gallus. In the early days, the preparation of polyclonal antibodies in mammals is through the extraction of tissue protein, but the purified tissue protein was complex and unstable [35], which is difficult to meet the requirements of a single immunogen. The prokaryotic expression system can express a large number of target protein in a short time, and the target protein was easy to purify [36,37].
Peroxisome proliferator-activated receptor α (PPARα) play a key role in the regulation of metabolic homeostasis, inflammation, cellular growth, and differentiation. To further explore the potential role of PPARα in the energy homeostasis of fatty liver hemorrhagic syndrome (FLHS), we reported the prokaryotic expression and purification of chicken PPARα subunit protein, and successfully prepared a polyclonal antibody against PPARα recombinant protein. The 987 bp PPARα subunit genes were cloned into the pEASY-T3 clone vector. Then the plasmid PCR products encoding 329 amino acids were ligated to pEASY-Blunt E2 vector and transformed into BL21 to induce expression. The recombinant PPARα subunit protein, containing His-tag, was purified by affinity column chromatography using Ni-NTA affinity column. Rabbit antiserum was generated by using the concentration of recombinant PPARα subunit protein as the antigen. The results of western blotting showed that the antiserum can specifically recognize chicken endogenous PPARα protein. Immunohistochemistry and immunofluorescence showed that the PPARα mainly existed in the nucleus of hepatocytes, renal epithelial cells and hypothalamic endocrine nerve cells. More importantly, western blotting and real-time quantitative PCR indicated that FLHS significantly decreased the expression of PPARα.
Prokaryotic expression of the chicken xanthine oxidase (XOD) subunit and its localization in liver and kidney
2016, International Journal of Biological Macromolecules
Citation Excerpt :
Previous study reported that sometimes due to the hyperactivity of XOD occurred in the body, the by-products of both uric acid and ROS would play an important role in various pathophysiological conditions [4]. In work on mammals, the XOD proteins were always extracted and purified from the liver and milk to produce the polyclonal antibody for the further study of the relationship between the ischemia-reperfusion damage and the XOD [16–18]. The former studies of chicken XOD was also reported the way of extracted and purified XOD from liver for the study of the function and structure of the chicken XOD [1,19].
Xanthine oxidase (XOD) is the members of the molybdenum hydroxylase flavoprotein family and it plays a vital role in the body’s purine catabolism. In this study, we cloned the XOD 37 kDa subunit protein by using RT-PCR and pMD-18-T clone vector based on the total RNA extracted from chicken liver. The cloning XOD subunit protein gene was ligated into the pET-32a to construct the recombinant plasmid pET-XOD. After the pET-XOD expression vector was transformed into host cells Rosetta (DE3), the recombinant XOD subunit proteins (54.8 kDa) were successfully induced by isopropy1 β-d-thiogalactoside (IPTG). Rabbit antiserums were produced by using the purification of the recombinant XOD subunit protein as antigen. The titer of the antiserum was more than 1:102,400 determined by using ELISA. The result of Western blot demonstrated that the antiserum could specifically recognize the chicken liver XOD. Immunohistochemistry and immunofluorescence showed that the XOD mainly presented in the cytoplasm of chicken hepatocytes and proximal tubular epithelial cells. Our results indicated that the XOD subunit protein polyclonal antibody prepared by this method could be used for the further researches of the biological function of the XOD in the chicken.
The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion
2012, Pharmacology and Therapeutics
Citation Excerpt :
These results contradict allopurinol-mediated free-radical reduction. Xanthine oxidase is readily expressed in endothelial cells that line the myocardial vasculature (Hellsten-Westing, 1993; Moriwaki et al., 1993), thus allopurinol may protect the myocardium by reducing post-ischemic O2•– production in endothelial cells. Alternatively, allopurinol has been shown to improve post-ischemic myocardial function independently of xanthine oxidase inhibition (Godin & Bhimji, 1987; Chambers et al., 1992; Hopson et al., 1995), an intrinsic antioxidant mechanism (Peterson et al., 1986) and cellular metabolic modulation (Ekelund et al., 1999; Cappola et al., 2001) have been proposed.
Myocardial ischemia-reperfusion injury is an important cause of impaired heart function in the early postoperative period subsequent to cardiac surgery. Reactive oxygen species (ROS) generation increases during both ischemia and reperfusion and it plays a central role in the pathophysiology of intraoperative myocardial injury. Unfortunately, the cellular source of these ROS during ischemia and reperfusion is often poorly defined. Similarly, individual ROS members tend to be grouped together as free radicals with a uniform reactivity towards biomolecules and with deleterious effects collectively ascribed under the vague umbrella of oxidative stress. This review aims to clarify the identity, origin, and progression of ROS during myocardial ischemia and reperfusion. Additionally, this review aims to describe the biochemical reactions and cellular processes that are initiated by specific ROS that work in concert to ultimately yield the clinical manifestations of myocardial ischemia-reperfusion. Lastly, this review provides an overview of several key cardioprotective strategies that target myocardial ischemia-reperfusion injury from the perspective of ROS generation. This overview is illustrated with example clinical studies that have attempted to translate these strategies to reduce the severity of ischemia-reperfusion injury during coronary artery bypass grafting surgery.
Effects of Oligonol®, an oligomerized polyphenol formulated from lychee fruit, on serum concentration and urinary excretion of uric acid
2011, Journal of Functional Foods
Epidemiological observations and laboratory studies have suggested that polyphenols possess anti-inflammatory, anti-microbial, anti-carcinogenic, and antioxidant properties. However, studies assessing the effects of polyphenols on uric acid metabolism in vivo are scarce. Herein, we investigated whether a phenolic substance, Oligonol®, has effects on uric acid metabolism. In six healthy male volunteers, Oligonol® significantly decreased 1-h uric acid excretion and fractional uric acid clearance, which was accompanied by a decreased serum concentration of uric acid. In addition, an in vitro experiment showed that Oligonol® inhibited buttermilk xanthine oxidase activity in a dose-dependent manner. Together, these results suggest that Oligonol® lowers serum uric acid through inhibition of xanthine oxidase, and may be effective for prevention and treatment of hyperuricemia and/or gout.
Be different-The diversity of peroxisomes in the animal kingdom
2010, Biochimica et Biophysica Acta - Molecular Cell Research
Peroxisomes represent so-called “multipurpose organelles” as they contribute to various anabolic as well as catabolic pathways. Thus, with respect to the physiological specialization of an individual organ or animal species, peroxisomes exhibit a functional diversity, which is documented by significant variations in their proteome. These differences are usually regarded as an adaptational response to the nutritional and environmental life conditions of a specific organism. Thus, human peroxisomes can be regarded as an in part physiologically unique organellar entity fulfilling metabolic functions that differ from our animal model systems. In line with this, a profound understanding on how peroxisomes acquired functional heterogeneity in terms of an evolutionary and mechanistic background is required. This review summarizes our current knowledge on the heterogeneity of peroxisomal physiology, providing insights into the genetic and cell biological mechanisms, which lead to the differential localization or expression of peroxisomal proteins and further gives an overview on peroxisomal biochemical pathways, which are specialized in different animal species and organs. Moreover, it addresses the impact of proteome studies on our understanding of differential peroxisome function describing the utility of mass spectrometry and computer-assisted algorithms to identify peroxisomal target sequences for the detection of new organ- or species-specific peroxisomal proteins.
Simultaneous determination of adenosine triphosphate and its metabolites in human whole blood by RP-HPLC and UV-detection
2008, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
To obtain insight in mechanisms of action of extracellular adenosine triphosphate (ATP) and adenosine, a simple HPLC method has been optimized and applied to investigate ATP metabolism in human whole blood ex vivo. This method provided good chromatographic resolution and peak shape for all eight compounds within a 19 min run time. The baseline was clean, the lower limit of quantification was below 0.3 μmol/L for all adenine nucleotides and the method demonstrated good linearity. Within-day precision ranged from 0.7 to 5.9% and between-days from 2.6 to 15.3%. Simplicity and simultaneous detection of ATP and its metabolites make this method suitable for clinical pharmacokinetic studies.

View all citing articles on Scopus

View full text

Purification and immunohistochemical tissue localization of human xanthine oxidase

Abstract

Anal. Biochem.

J. Mol. Cell. Cardiol.

Cell

Comp. Biochem. Physiol.

Arch. Biochem. Biophys.

J. Biol. Chem.

FEBS Lett.

Arch. Biochem. Biophys.

Biochim. Biophys. Acta